Foreign Secretary Marcelo Ebrard announced that Johnson & Johnson’s pharmaceutical company Janssen began phase 3 of her vaccine trials in Mexico.
“I congratulate Janssen who started phase 3 of his vaccine project in Mexico, welcome and wish them the greatest success in their work,” he wrote on Twitter.
I congratulate janssen who started phase 3 of his vaccine project in Mexico, welcome and wish them the greatest success in their work.
— Marcelo Ebrard C. (@m_ebrard) December 5, 2020
According to the Undersecretary of Prevention and Promotion of Health, Hugo López-Gatell, eight other countries besides Mexico are participating in Janssen’s clinical trial.
Lopez-Gatell said that up to 20,000 people are planned for Phase 3 trials and that the volunteer information collection process is likely to be closed on December 21 for analysis.
“By participating in the clinical trial, Mexico is eligible for prioritization by Janssen for its highly effective vaccine,” he said.
Find out: 8 things we know so far about the application of COVID vaccines in Mexico
In addition to Janssen, the pharmaceutical company CanSino Biologics is also in phase 3 of testing its COVID-19 vaccine.
Recently, both Chancellor Ebrard and CDMX Head of Government Claudia Sheinbaum invited people to volunteer in clinical trials of this vaccine.
Vaccine conventions
Mexico has signed COVID-19 vaccine pre-buy agreements to protect up to 116 million people, Marcelo Ebrard said on 13 October.
So far there are agreements with AstraZeneca, Pfizer, CanSinoBio and the COVAX mechanism of the Pan American Health Organization.
You may be interested: Vaccines won’t eliminate the pandemic, they don’t mean zero COVID, WHO warns
With AstraZeneca, there are pre-buys for 77.4 million doses, while 35 million doses of Chinese pharmaceutical company CanSinoBio are agreed.
With Pfizer there is an agreement of 34 million doses and the COVAX mechanism contemplates 51.5 million doses.
So far Mexico has 1,156,770 confirmed cases of COVID-19 and 108,863 dead.
What we do at Animal Politics requires professional journalists, teamwork, dialogue with readers and something very important: independence. You can help us keep going. Be part of the team.
Subscribe to Animal Politics, receive benefits and support free journalism.#YoSoyAnimal
